If you have a high risk of negative side effects from a medication — or a strong chance that a drug won’t work for you — you want to know. That knowledge may come from pharmacogenomics.
Researchers have started to answer important questions: Can we predict the severity of rheumatoid arthritis, and can we predict how patients will respond to aggressive treatment?
The decision to have your ovaries and fallopian tubes removed does not come easily. But if you face an alarmingly high genetic risk of ovarian cancer, sometimes this preventive surgery is the right option.
Who should be tested — and when? These are the big questions people ask when it comes to genetic screening, especially for commonly known mutations. Get expert insight.
Is the at-home Cologuard test a way to offer more early detection for colon cancer—and an alternative to colonoscopy? An expert weighs in.
When it comes to heart disease, there are plenty of factors you can’t control — including aging and your family history. But even if you can’t turn back time, you can get clarity and manage your risk with the help of genetics.
Your genes tell a story of health and disease risk — and they tell that story from the day you are born. Two experts answer questions about the state of early genomic sequencing.
When a genetic mutation makes headlines, the first thing patients ask is, “Should I be tested for it?”
When basketball star Isaiah Austin stood in front of the crowd at June’s NBA draft, the moment had special meaning for people with genetic conditions.
According to a new study, people with a certain genetic mutation have a higher chance of developing cancer not once, but twice. Find out what the research means for patients.